A rise in incidence rates of childhood-onset type I diabetes has been reported in recent years in children under 15 y of age at diagnosis. The evaluation performed by the large European network EURODIAB has shown an annual increase of 3.2% between 1989 and 1998 (1) , confirming that the increase in incidence in children is real. Among the children under 15 y of age, the rise in incidence seems to be higher in the youngest children. This has been described in some studies performed in more restricted areas with a longer period of observation (2) (3) (4) (5) , and has recently been confirmed by EURODIAB. The question arises whether the observed increase in incidence rates in childhood reflects an actual rise in the frequency of the disease over lifetime, or whether there is a shift toward a younger age at onset of type I diabetes, reflecting a more aggressive form of the autoimmune disease. Because no data on incidence trends of type I diabetes over lifetime are available, it is impossible to draw a conclusion based on current knowledge.
The French register of incidence of insulin-dependent diabetes in children registered cases occurring under the age of 20 y from 1988 to 1997. The aims of this study were to quantify the increase of incidence of type I diabetes in children, with a particular interest for the 0 -4 y age group, and to describe the incidence trend in the 15-19 y age group.
SUBJECTS AND METHODS

Registration of cases.
The functioning of the French register of incidence of insulin-dependent diabetes has been described in detail elsewhere (6) . This prospective registration met the inclusion criteria of the EURODIAB Study, using two direct and independent sources of identification of cases (7) . The various hospital units for adults and children as well as private hospitals and practitioners in private practice were selected as the primary source of information. Data of the French national health insurance (Social Security) was the secondary independent source of identification of cases. The rate of ascertainment of cases was calculated using the "capture recapture" method (8), and was Ͼ95% over the study period (9) . The register was operated between January 1, 1988, and December 31, 1997. All cases of type I diabetes occurring between these two dates were included. Type I diabetes was diagnosed accorded to the World Health Organization criteria (10), together with a permanent need for insulin therapy, and secondary cases were excluded. As illustrated in Figure 1 , the study areas covered four French counties: Aquitaine, Lorraine, Basse-Normandie, and HauteNormandie, covering a population of more than 2 million subjects aged Ͻ20 y. These four counties reflect the diversity of the French population. For example, Basse-Normandie and Aquitaine are more rural and Haute-Normandie and Lorraine are more industrial areas. The population density was lowest in Basse-Normandie. The study area includes three cities of more than 300,000 inhabitants.
Calculation of incidence rates. The numerators were made by all cases identified by either source.
Age was calculated for each individual as the full attained age on the first day of insulin therapy. The population numbers were provided by the Institut National de la Statistique et des Etudes Economiques (INSEE). They are available for each age group, for both genders, and for each county for each of the 10 individual years of the study (11). Details for the study population can be seen in Table 1 for the first and the last years of the study, as an indicative example.
Incidence rates were calculated for the overall study population, for each age group (0 -4 y, 5-9 y, 10-14 y, and 15-19 y), and for each gender. Standardized incidence rates were calculated based on a direct standardization assuming the standard population to be distributed in groups of equal size, defined by age groups and/or gender.
Statistical analysis. The trend in incidence rates was tested using a linear regression, where the standardized incidence rate was the dependent variable and the calendar year the independent variable. In each age group, a departure from linear trend Yearly age-and sex-adjusted incidence rates for the overall study population (number of cases per 100 000), and yearly age-adjusted incidence rates in boys and in girls (number of cases per 100 000) of type I diabetes in children aged under 20 y, in four counties of France during 1988 -1997.
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was tested by comparing two models: one with the calendar year, and one with the calendar year together with the square of this variable.
For the analysis by gender, the parallelism of the linear regression lines fitted in each group was tested. An analysis of covariance was performed if the slopes could be considered as equal.
The analyses were performed using the STATA statistical software release 7.0 (Stata Corporation College Station, TX, U.S.A.).
RESULTS
A total of 1867 eligible patients were included in the present study (Table 2 ).
In the overall population, the age-and sex-adjusted incidence rate increased from 7.41 per 100,000 per year [95% confidence interval (CI): 6.55-8.27] in 1988 to 9.58 per 100,000 per year (95% CI: 8.64 -10.52) in 1997. The average increase was 0.28 per 100,000 per year (95% CI: 0.19 -0.36; p ϭ 0.0001). There was no significant departure from linear trend (p ϭ 0.17). As shown in Figure 2 , the percentage rise in incidence was greatest in the 0 -4 y age group, whereas the sex-adjusted annual incidence was 4.17 per 100,000 per year (95% CI: 2.64 -5.70) in 1988 and 7.48 per 100,000 per year (95% CI: 5.63-9.27) in 1997. Consequently, an increase of 78% was observed over 10 y in this age group. A significant departure from linear trend was found (t ϭ 2.58, p ϭ 0.036). In none of the other age-groups was a significant departure from linear trend observed. Incidence rates rose linearly and significantly in the 5-9 y [0.43/100,000/y (95% CI: 0.13-0.74), p ϭ 0.011] and 10 -14 y [0.40/100,000/y (95% CI: 0.20 -0.60), p ϭ 0.002] age groups. In contrast, there was no significant change in incidence rates in the 15-19 y age group, with a regression slope of Ϫ0.02 per 100,000 per year (95% CI: Ϫ0.18 to 0.14, p ϭ 0.77). The annual increase was 4.2% per year (95% CI: 2.8 -5.5) in the 0 -14 y age group.
The rise in incidence was not statistically different between the two genders (p ϭ 0.20), but a consistently higher incidence rate over years was found in boys in comparison to girls (analysis of covariance: F 1,17 ϭ 10.15, p ϭ 0.005).
There were no statistically significant differences in incidence rates between the four counties over the study. The only difference was that no statistically significant increase could be seen in Basse-Normandie over the study period, whereas the other three counties showed indeed a significant increase of comparable magnitude.
DISCUSSION
This 10-y study of incidence of type I diabetes in children shows an increase in incidence rates in France at the same Figure 2 . Time course of incidence rates across age groups. Sex-adjusted incidence rates (number of cases/100,000/y Ϯ SD) of type I diabetes in children aged 0 -4, 5-9, 10 -14, and 15-19 y in France during 1988 -1997, together with the regression curve when a significant departure from linear trend was seen (for the 0 -4 y age group), or the regression line (solid line) when no significant departure from linear trend was seen (for the 5-9, 10 -14, and 15-19 y age groups). In the bottom panel, the dotted line is the regression line for 0 -4 y age group. Population at risk during the first and the last years of the study in each age group for the two genders.
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order of magnitude as in other European countries. Nevertheless, a specific pattern of increase was found in the 0 -4 y age group, contrasting with stable rates in the 15-19 y age group. The increasing number of cases registered under the age of 15 y could not be explained by a change in the definition of type I diabetes, by a general-population screening, or by a reduced number of deaths at onset before registration because no major modification in the health care system had taken place over the period of the study in this country. Therefore, those prospective incidence data clearly confirm the rise in incidence of type I diabetes in children that was observed in the most recent studies (2, 4, 5) .
Despite the steeper rise in incidence in children aged 0 -4 y, this increase in the youngest age group does not entirely account for the overall rise in incidence of type I diabetes, since a significant increase was also observed in the 5-9 y and 10 -14 y age groups. This makes the epidemiologic situation different from that observed in Switzerland (5), where the rise in incidence of type I diabetes in children below 15 y of age was entirely due to the contribution of the 0 -4 y age group between 1991 to 1999.
Our data show that the incidence remained stable in the 15-19 y age group. This age group has been rarely studied. In agreement with our observation, a Polish study showed no modification of incidence in the 15-29 y age group from 1994 to 1998, whereas an increase was seen below 15 y of age (12) .
The specific pattern of rise in incidence rates of type I diabetes that is therefore observed for the first time suggests a shift toward a younger age at onset of the disease. Some evidence for such a shift has been given by studies showing the greatest increase in the youngest age groups, namely EURO-DIAB (1) and studies in Finland (3), the United Kingdom (2), and Switzerland (5). Furthermore, a Swedish cohort study documented a shift toward a younger age at onset of type I diabetes among children under 15 y (4).
Such an increase in incidence of type I diabetes over a period of 10 years does not reflect a modification in the genetic background of the study population. More likely it suggests that environmental factors interact with a genetic susceptibility and lead to a more aggressive form of the disease with an earlier age at onset of the clinical disease.
CONCLUSION
Incidence rates of type I diabetes rose in France between 1988 and 1997 for children below 15 y of age, with a specific pattern of acceleration in children below 5 y of age. The incidence rates were stable in the 15-19 y age group. This specific pattern of increase argues for a shift toward a younger age at onset, which contributes, at least in part, to the observed increase in incidence of type I diabetes in children. This might be explained by the role of early environmental events in highly genetically susceptible children. Further studies are needed to assess the evolution of incidence rates in the adult population to confirm this hypothesis.
